ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 59 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,467,028 | +40.6% | 1,349,038 | +59.7% | 2.47% | +52.2% |
| Q1 2024 | $2,465,928 | -15.4% | 844,496 | -33.1% | 1.63% | -26.3% |
| Q4 2023 | $2,914,201 | +42.9% | 1,261,559 | +61.5% | 2.21% | +17.8% |
| Q3 2023 | $2,039,172 | -33.0% | 781,292 | -8.1% | 1.87% | -31.6% |
| Q2 2023 | $3,043,000 | +2.9% | 850,000 | -37.3% | 2.74% | +7.1% |
| Q1 2023 | $2,955,917 | – | 1,355,925 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 681,500 | $2,481,000 | 1.19% |
| DAFNA Capital Management LLC | 26,000 | $95,000 | 0.04% |
| Rossmore Private Capital | 15,061 | $55,000 | 0.02% |
| Sterling Investment Advisors, Ltd. | 3,150 | $11,000 | 0.01% |
| Close Asset Management Ltd | 7,500 | $27,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 1,500 | $5,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,506 | $5,000 | 0.00% |
| MORGAN STANLEY | 26,701 | $97,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,600 | $6,000 | 0.00% |